What women with ovarian cancer think and know about genetic testing - Wikidata - awgldk - TriplyDB

What women with ovarian cancer think and know about genetic testing

What women with ovarian cancer think and know about genetic testing

http://www.wikidata.org/entity/Q37103527

about

Genetics Consultation Rates Following a Diagnosis of High-Grade Serous Ovarian Carcinoma in the Canadian Province of Ontario.Awareness, knowledge, perceptions, and attitudes towards genetic testing for cancer risk among ethnic minority groups: a systematic review.A pilot study of hereditary breast and ovarian knowledge among a multiethnic group of Hispanic women with a personal or family history of cancer Awareness, perceptions, and provider recommendation related to genetic testing for hereditary breast cancer risk among at-risk Hispanic women: similarities and variations by sub-ethnicity A clinical perspective on genetic counseling and testing during end of life care for women with recurrent progressive ovarian cancer: opportunities and challenges.Awareness of direct-to-consumer genetic tests and use of genetic tests among Puerto Rican adults, 2009.Ethical concerns related to developing pharmacogenomic treatment strategies for addiction.Concerns about cancer risk and experiences with genetic testing in a diverse population of patients with breast cancer.Important considerations for recruiting women to cancer genetics studies in Puerto Rico.Genetic risk assessment for women with epithelial ovarian cancer: referral patterns and outcomes in a university gynecologic oncology clinic.Acceptance of, inclination for, and barriers in genetic testing for gene mutations that increase the risk of breast and ovarian cancers among female residents of Warsaw Effects of disclosing hypothetical genetic test results for salt sensitivity on salt restriction behavior.Adherence patterns to National Comprehensive Cancer Network (NCCN) guidelines for referral to cancer genetic professionals Underestimation of risk of a BRCA1 or BRCA2 mutation in women with high-grade serous ovarian cancer by BRCAPRO: a multi-institution study.Does a medical history of hypertension influence disclosing genetic testing results of the risk for salt-sensitive hypertension, in primary care?Timing of referral for genetic counseling and genetic testing in patients with ovarian, fallopian tube, or primary peritoneal carcinoma.Bumps along the translational pathway: anticipating uptake of tailored smoking cessation treatment Evaluating women with ovarian cancer for BRCA1 and BRCA2 mutations: missed opportunities.The effect of a celebrity health disclosure on demand for health care: trends in BRCA testing and subsequent health services use.Influence of family history on the willingness of outpatients to undergo genetic testing for salt-sensitive hypertension: a cross-sectional study.Development of an integrated support system for hereditary cancer and its impact on gynecologic services.Cancer Genetic Counseling and Testing: Perspectives of Epithelial Ovarian Cancer Patients and Gynecologic Oncology Healthcare Providers.Missed therapeutic and prevention opportunities in women with BRCA-mutated epithelial ovarian cancer and their families due to low referral rates for genetic counseling and BRCA testing: A review of the literature.Disentangling the determinants of interest and willingness-to-pay for breast cancer susceptibility testing in the general population: a cross-sectional Web-based survey among women of Québec (Canada).

P2860

Q33669849-4D6541EF-4729-43BF-9EAE-AB750E8CE397 Q33730576-A929E49E-97FD-4A79-B7D9-CACB3B1C5FB0 Q34112119-061DC8E1-9824-4604-B666-8C350F37AF12 Q34311421-CD15D696-9DB0-4395-AC0C-6983316653E7 Q34856782-88B029F6-43B2-4C45-899C-F6944BF3E38A Q35235138-DCDEB521-E74C-4887-AAF6-78B1176E185D Q35286480-D57FCC7A-245D-4DF0-8FCC-0EEF5ED2E14B Q35563836-2343377F-4611-48D2-B656-0D4945B8C3AF Q35926563-4DB98C4C-80BA-4B9A-A438-A590550B7B5E Q36108520-FCEF4D87-5DE6-4749-A9F9-E2AB7CD2F95D Q36792901-25D814AF-5A98-46EB-99A6-580AEE2A32F4 Q36857222-C68AC688-714F-45E7-8058-40AB95F161AA Q36904144-7194BC50-B22D-4D10-B90B-08C427A86719 Q36925152-FB9173D4-1996-47A3-AB75-D4792BF69234 Q37143257-2FF0E870-98EE-4D2C-AE93-99F496B7F5FF Q37395951-0BE55FB9-50CA-4ECA-93B4-84E2ACC82F98 Q37438867-72A8DEAF-10AE-420E-9A22-047049F5DF15 Q37629639-B0B0DA75-E1CF-46C9-BADF-80C431C2CAAA Q37746657-2471A2AE-85D5-413C-82D7-44DEB47678E2 Q41227652-BF171157-6C21-449B-B7E6-5EBDE7E35178 Q43749121-0AEFE5EA-A024-4925-BC5B-396CCA39F2C7 Q46109910-B41B5E3F-23EC-4A4A-9F59-041FE996415A Q48110433-F3FB77E0-FAED-47D8-ABC8-9F411331ED15 Q52682549-95980CA7-45D9-49E4-B69F-7ABE565AAFE6

P2860

What women with ovarian cancer think and know about genetic testing

http://www.wikidata.org/entity/Q37103527

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 06 August 2008

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

What women with ovarian cancer think and know about genetic testing

@en

What women with ovarian cancer think and know about genetic testing.

@nl

type

label

What women with ovarian cancer think and know about genetic testing

@en

What women with ovarian cancer think and know about genetic testing.

@nl

prefLabel

What women with ovarian cancer think and know about genetic testing

@en

What women with ovarian cancer think and know about genetic testing.

@nl

P1433

Q37103527-74A5B753-49A3-4EC6-B29D-3BC8643595A4

P1476

Q37103527-B03C43C0-4713-4DC9-A9E4-32EDA6E540DB

P2093

Q37103527-157300E8-8A9B-482B-909A-B32EAA9747BE

Q37103527-41F8B447-59C9-466E-9F63-214B28562333

Q37103527-4B1994BE-B6A5-469E-9FDD-5760997D29FB

Q37103527-5B4FBA50-2006-42BD-91EA-E5F99B368930

Q37103527-77D7B9AE-C5C9-40AA-8840-20A37FA407C0

Q37103527-8B358C61-5006-4FF1-A633-AE307E091C03

Q37103527-9F86718A-5E76-4D0C-A363-742E410A9AE1

Q37103527-DB846632-E71F-4FB2-AC04-4640237D3A6D

Q37103527-F85E8501-F250-4E74-80ED-CAD081482C67

P2860

Q37103527-082899BB-9F1E-45C3-A404-8341CBF707DA

Q37103527-0C898DED-852A-4C65-8495-D12A21AA8E3F

Q37103527-2297F912-E258-4524-9EBA-1CB6EFC4A1C1

Q37103527-310A81B0-F1C3-412F-8CCF-15CE3760E9FC

Q37103527-6AC3B55E-CA1A-4E36-81AC-FE892A826B88

Q37103527-8227897E-9510-4A86-AA2F-F5FB35C5E1CA

Q37103527-842DE85B-F99D-4066-A55E-EE1D05C73500

Q37103527-A7990FC2-95C4-4163-95B0-EBBBECCDB405

Q37103527-AC116B16-D66D-408E-BDD5-E30A4C00A9AB

Q37103527-E436F9AB-A2E1-4614-A23E-3847CFF273C3

P304

Q37103527-41B974DB-1AD7-4BCC-B389-5326257F0F75

P31

Q37103527-D669A6D0-5CFC-456D-9C47-C03D226DDA9B

P356

Q37103527-BE2C77FA-90BD-4F3C-A53C-19303D4CA1E2

P407

Q37103527-7467DDB7-7776-40F9-8D8E-EAD4A50E9697

P433

Q37103527-D197D563-5BFB-4519-A295-3964D8148224

P478

Q37103527-B3CDBDF3-7B88-4F53-A767-902C92ECABA4

P50

Q37103527-2841E492-B99A-4E7B-9F57-CA72BCA73649

P577

Q37103527-B8D7DAC9-7933-473F-85EF-05BFFB99E124

P698

Q37103527-735746C3-DEB5-4096-BC2A-AED7F9BA65B0

P921

Q37103527-91C08396-F225-4A53-972E-7E8980D17BBD

P932

Q37103527-7BEAEA57-EA8B-4CDA-A1C6-FF026DE5CEF6

P356

J.YGYNO.2008.06.016

P1433

Gynecologic Oncology

P1476

What women with ovarian cancer think and know about genetic testing

@en

P2093

Catherine C Burke

http://www.w3.org/2001/XMLSchema#string

Karen H Lu

http://www.w3.org/2001/XMLSchema#string

Kimberly A Burns

http://www.w3.org/2001/XMLSchema#string

Larissa A Meyer

http://www.w3.org/2001/XMLSchema#string

Nicki F Webb

http://www.w3.org/2001/XMLSchema#string

Robin A Lacour

http://www.w3.org/2001/XMLSchema#string

Shannon N Westin

http://www.w3.org/2001/XMLSchema#string

Shiney Kurian

http://www.w3.org/2001/XMLSchema#string

Terri B Pustilnik

http://www.w3.org/2001/XMLSchema#string

P2860

Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy

Cancer statistics, 2008

Prevalence and penetrance of germline BRCA1 and BRCA2 mutations in a population series of 649 women with ovarian cancer

PARP-1 inhibitors: are they the long-sought genetically specific drugs for BRCA1/2-associated breast cancers?

Psychosocial predictors of BRCA counseling and testing decisions among urban African-American women.

Barriers to participating in genetic counseling and BRCA testing during primary treatment for breast cancer.

Increased uptake of BRCA1/2 genetic testing among African American women with a recent diagnosis of breast cancer.

BRCA1 and BRCA2 mutations account for a large proportion of ovarian carcinoma cases.

Clinical characteristics of individuals with germline mutations in BRCA1 and BRCA2: analysis of 10,000 individuals.

Psychosocial factors associated with the public's willingness to pay for genetic testing for cancer risk: a structural equations model.

P304

132-136

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.YGYNO.2008.06.016

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

111

http://www.w3.org/2001/XMLSchema#string

P50

Molly S. Daniels

P577

2008-08-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

18684498

http://www.w3.org/2001/XMLSchema#string

P921

P932

3746752

http://www.w3.org/2001/XMLSchema#string